IQVIA™ Real-World Insights Bibliography

Leveraging unstructured data to identify hereditary angioedema patients in electronic medical records
Author(s): Emily S Brouwer 1 , Emily W Bratton 2 , Aimee M Near 2 , Lynn Sanders 1 , Christina D Mack 2
Affiliations(s): 1 Takeda Pharmaceutical Company Limited, 300 Shire Way, Lexington, MA, USA. 2 IQVIA, Durham, NC, USA.
Publication(s):  Allergy Asthma Clin Immunol . 2021 Apr 20;17(1):41. doi: 10.1186/s13223-021-00541-6.
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Rare disease,
2021
  L:
A:
English
Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
Epidemiology of Concussion in the National Football League, 2015-2019
Author(s): Christina D Mack 1, Gary Solomon 2 3, Tracey Covassin 4, Nicholas Theodore 5, Javier C├írdenas 6, Allen Sills 2 3
Affiliations(s): 1 IQVIA, Durham, NC, USA. 2 Department of Neurological Surgery and Vanderbilt Sports Concussion Center, Vanderbilt University School of Medicine, Nashville, Tennessee 3 National Football League Player Health and Safety Department, New York, New York 4 Department of Kinesiology, Michigan State University, East Lansing, Michigan 5 Department of Neurological Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 6 Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona
Publication(s):  Sports Health . 2021 Apr 19;19417381211011446. doi: 10.1177/19417381211011446.
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Injuries,
2021
  L:
A:
English
Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason
Author(s): Christina D. Mack; John DiFiori; Caroline G. Tai; Kristin Y. Shiue; Yonatan H. Grad; Deverick J. Anderson; David D. Ho; Leroy Sims; Christopher LeMay; Jimmie Mancell; Lisa L Maragakis
Affiliations(s): 1 IQVIA, Durham, NC, USA (Mack, Tai, Shiue) 2 Hospital for Special Surgery (DiFiori) 3 National Basketball Association, New York, New York (DiFiori, Sims, LeMay) 4 Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Grad) 5 Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina (Anderson) 6 Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York (Ho) 7 Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee(Mancell) 8 Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland (Maragakis)
Publication(s):  JAMA Intern Med. Published online April 22, 2021. doi:10.1001/jamainternmed.2021.2114
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools
Author(s): Elvira D'Andrea, Lydia Vinals, Elisabetta Patorno, Jessica M. Franklin, Dimitri Bennett , Joan A. Largent, Daniela C. Moga, Hongbo Yuan, Xuerong Wen, Andrew R. Zullo, Thomas P. A. Debray, Grammati Sarri
Affiliations(s): D'Andrea: Harvard; Largent: IQVIA
Publication(s):  http://orcid.org/0000-0002-5263-3964PubMed articles
Document Type(s): Article,
Countries: Europe, USA,
Click here for the abstract
C:
Y:
Methodology,
2021
  L:
A:
English
Literature Review,
  Add to report
 
 
Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making
Author(s): Grammati Sarri 1, Elisabetta Patorno 2, Hongbo Yuan 3, Jianfei Jeff Guo 4, Dimitri Bennett 5, Xuerong Wen 6, Andrew R Zullo 7, Joan Largent 8, Mary Panaccio 9, Mugdha Gokhale 10, Daniela Claudia Moga 11, M Sanni Ali 12 13 14, Thomas P A Debray 15 16
Affiliations(s): 1Real World Evidence Sciences, Visible Analytics Ltd, Oxford, UK grammati.sarri@visibleanalytics.co.uk. 2Division of Pharmacoepidemiology and Pharmacoeconomics, Dept. of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 3Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, Ontario, Canada. 4Department of Pharmacy Practice & Administrative Sciences, University of Cincinnati College of Pharmacy, Cincinnati, Ohio, USA. 5Takeda, Cambridge, Massachusetts, USA. 6Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA. 7Health Services, Policy, and Practice, Brown University, Providence, Rhode Island, USA. 8Real-World Solutions, IQVIA, California, Colorado, USA. 9Epidemiology and Outcomes Research, Research Outcomes Innovations LLC, New York City, New York, USA. 10GlaxoSmithKline USA, Philadelphia, Pennsylvania, USA. 11University of Kentucky, Department of Pharmacy Practice and Science, Lexington, Kentucky, USA. 12NDORMS, Center for Statistics in Medicine, University of Oxford, Oxford, UK. 13Department of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 14Department of Public Heath, Environments and Society, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 15Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands. 16Smart Data Analysis and Statistics, Utrecht, The Netherlands.
Publication(s):  PMID: 33298465 DOI: 10.1136/bmjebm-2020-111493
Document Type(s): Article,
Countries: Europe, USA,
Click here for the abstract
C:
Y:
Methodology,
2021
  L:
A:
English
Literature Review,
  Add to report
 
 
Use of Low Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitors (PCSK9i) Initiation
Author(s): Rymer JA, Mues KE, Monda KL, Bratton EW, Wirtz HS, Okerson T, Overman RA, Brookhart MA, Muntner P, Wang TY
Affiliations(s): From the Duke Clinical Research InstituteDurham NC (J.A.R., T.Y.W.); Center for Observational ResearchAmgen IncThousand Oaks CA (K.E.M., K.L.M., H.S.W., T.O.); IQVIA, Real?World Evidence SolutionsDurham NC (E.W.B.); NoviSci, IncDurham NC (R.A.O., M.A.B.); University of North Carolina at Chapel HillChapel Hill NC (M.A.B.); Department of EpidemiologyUniversity of Alabama at BirminghamAL (P.M.).
Publication(s):  Originally published24 Apr 2020https://doi.org/10.1161/JAHA.119.014347Journal of the American Heart Association. ;0:e014347
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Cardiovascular disease, Medication compliance,
2020
  L:
A:
English
Epidemiological study,
  Add to report
 
 
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
Author(s): Gerard E.Franciscoa; Daniel S.Bandari; Ganesh Bavikattec; Wolfgang H.Jost; Emily McCusker; Joan Largent; Alekse Zuzek; Alberto Esquenazi
Affiliations(s): a The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA b Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA c The Walton Centre, Liverpool, UK d University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany e Parkinson-Klinik Ortenau, Wolfach, Germany f Allergan, an AbbVie Company, Irvine, CA, USA g IQVIA Real-World Evidence Solutions, Cambridge, MA, USA h MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA
Publication(s):  PM R . 2020 Jan 17. doi: 10.1002/pmrj.12328.
PMID: 31953896 DOI: 10.1002/pmrj.12328
Document Type(s): Article,
Countries: Asia Pacific, Europe, USA,
Click here for the abstract
C:
Y:
Drug Utlization Study, Medication compliance,
2020
  L:
A:
English
Methodology, Observational study,
  Add to report
 
 
Who owns patient data? The answer is not that simple
Author(s): Alison Bourke, Georgina Bourke
Affiliations(s): Scientific Director, Centre of Advanced Evidence Generation, IQVIA, and Past President of the International Society for Pharmacoepidemiology. Designer and Strategist at Projects by IF, a technology studio that focuses on the ethical and practical uses of data and AI.
Publication(s):  BJMOpinion August 6, 2020
Document Type(s): Article,
Countries: UK, USA,
Click here for the abstract
C:
Y:
COVID-19, Health policy,
2020
  L:
A:
English
Market impact,
  Add to report
 
 
Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions
Author(s): Kristin M Sheffield , Nancy A Dreyer , James F Murray, Douglas E Faries & Megan N Klopchin
Affiliations(s): 1Global Patient Outcomes & Real World Evidence, Eli Lilly & Company, Indianapolis, IN 46225, USA 2IQVIA Real-World & Analytic Solutions, Cambridge, MA 02139, USA 3Real World Analytics, Eli Lilly & Company, Indianapolis, IN 46225, USA
Publication(s):  Published Online:11 Sep 2020https://doi.org/10.2217/cer-2020-0161
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Drug safety, Drug Utlization Study, Guidelines, Methodology, Public Health,
2020
  L:
A:
English
Methodology, Observational study, Population Based Study,
  Add to report
 
 
Combatting COVID-19 With Real-World Evidence
Author(s): Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD
Affiliations(s): Jennifer B. Christian, PharmD, MPH, PhD, is vice president of Clinical Evidence & Epidemiology, Real World Solutions, IQVIA Matthew W. Reynolds, PhD, is vice president, Real World Evidence, IQVIA
Publication(s):  AJMC.org (UVPM: 137,786)
September 7, 2020 Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Infectious disease,
2020
  L:
A:
English
Burden of illness, direct to patient research, Methodology,
  Add to report
 
 
 1 of 68 Next Page Last Page